Harpoon Therapeutics, Inc. announced the appointment of Alan Colowick, M.D., to its board of directors. Dr. Colowick is an experienced biotech leader and has served in numerous executive and board roles. Throughout his career, Dr. Colowick has had a broad impact across the healthcare landscape with a focus on clinical-stage companies in oncology, rare diseases and other specialty therapeutic areas. From May 2017 until January 2021, he served as a partner and executive partner with Sofinnova Ventures and led investments in Velos Biopharma, Xylocor, and InCarda.